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ADVANCES IN UNDERSTANDING WITH MODERN TECHNIQUES
P. J. Sadler
Chemistry Department, Birkbeek College, University of London
Interest in the effects of gold compounds on biological systems ranges
from their use for anti-inflammatory and anti-bacterial purposes to
the study of the method of uptake of gold by micro-organisms. By
the application of modern physical techniques new light is being
shed on the mechanism of action of gold in these areas.
Although living things have a natural requirement
for some metal ions, gold, as far as we know, is not
one of them. We see from a glance at the d-block
metals, Table I, that none of the other members of
the 3rd transition series are required, and that
molybdenum stands alone in the 2nd series. The
required ions activate particular biological pathways,
for example cobalt for vitamin B12 (prevents per-
nicious anaemia), iron for haemoglobin (transportation
of 02)' zinc for carbonic anhydrase (catalyses CO 2
hydration), copper for cytochrome oxidase (generates
metabolic energy), and so on. We notice that copper,
like gold, is in group IB and in some of its chemistry
resembles gold. Why is gold not a natural require-
ment ?
The low natural abundance and exceptional
stability of metallic gold are probably both con-
tributing factors. Living things have not developed a
mechanism for converting metallic gold into a soluble
form which can be utilised biochemically, However,
a few plants, living in gold-rich soils, can accumulate
gold (1, 2), perhaps helped by micro-organisms which
can secrete amino acids for the purpose of dissolution
(3). Concentrations of gold in plant ashes running
from ten- to thirty-fold the normal concentrations are
good indications of the sites of gold ores, although
there are, of course, differences in gold accumulation
between species; some types of grasses can accumu-
late as much as 100 grams of gold per ton.
The possibility arises of administering gold com-
pounds to living things to produce a therapeutic
effect—a thought that occurred to the Chinese in
2500 B.C.! Unlike them, we now have the tools for
examining the action of gold in intimate detail, as
will be appreciated from the illustration of Figure 1.
Chemotherapy
During those early times gold was regarded as a
universal remedy which would favourably affect the
course of all diseases. In the eighth century some
alchemists attempted to prepare from metallic gold
an elixir of life that would cure all diseases and confer
eternal youth (4). In the thirteenth century gold, in
the form of aurum potabile (gold dissolved in aqua
regia and diluted with oil of rosemary or other
essential oils) was recommended for the treatment of
leprosy and many other diseases. Writing in about
1250, the famous encyclopaedist Bartholomaeus
Anglicus extolled the virtues of gold for treating
"cardiacal passion", "evils of the spleen and other
evils", and even foreshadowed the use of gold for
treating rheumatoid diseases: "gold comforteth
Table
The d-Block Metals Essential for Living Things (shown in red)
Sc Ti V (r? Mn Fe Co Ni Cu Zn
Y Zr Nb Mo Tc Ru Rh Pd Ag Cd
La HI' Ta W Re Os Jr Pt Au Hg
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Fig. 1 By the use of a photochemical technique the target sites of the gold drug Myocrisin within the kidney
of a rat are revealed. In this kidney section sites of gold deposition appear black, cell nuclei are stained red
and the cell cytoplasm green. (B. Vernon-Roberts and J. L. Dore) >(350
lymmes ... it doth away with the sharpness of super-
fluities that growe in members and cleanseth them in
that wise". As recently as the late eighteenth century
gold was used for the treatment of nearly every illness,
but with no biochemical basis for such treatment it is
not surprising that confidence in its use was low.
It was Koch's discovery (5) in 1890 that KAu(CN) 2
was lethal to the micro-organism responsible for
tuberculosis (mycobacterium tuberculosis) in the
test tube that paved the way for a sounder basis for
gold therapy. This compound was administered to
tuberculosis sufferers but, although there were favour-
able results, there were also serious toxic side-effects.
Au(I)-thiols
After intensive synthetic efforts in the 1920s
several Au(I)-thiols, AuSR, were prepared which




Fig. 2 Graph showing the
number of papers on gold	 40
treatment in tuberculosis	 ►
during the years 1925-
1944. Of the first wave of 	 20	 1
publications before 1931
very few dealt primarily
with toxic effects (6) 




but much less toxic. Sodium aurothiosulphate (trade
name "Sanocrysin"), sodium aurothiomalate
("Myocrisin"), sodium aurothiopropanol sulphonate
("Allochrysine") and aurothioglucose ("Solganal-B-
Oleosum"), for example, all became popular. The
period 1925 to 1935, in which gold therapy in clinical
tuberculosis flourished, has been termed the Gold
Decade in tuberculosis treatment (6).
During this time Lande introduced these com-
pounds for the treatment of rheumatoid arthritis (7),
and it was quickly popularised by Forestier and
others. Lande was impressed by the anti-bacterial
effects, and assumed (mistakenly) that there was a
relationship between arthritis and tuberculosis.
However, after 1935 there was a rapid rejection of
gold drugs for tuberculosis treatment, without the
immediate introduction of a substitute drug. We see
from Figure 2 that interest waned in parallel with
reports of toxic side-effects. Clearly laboratory
groundwork on the curative effects was insecure and
adequate critical clinical trials were Iacking (6).
Disodium aurothiomalate and aurothioglucose,
Table II, remain in clinical use today for the treat-
ment of rheumatoid arthritis. Controlled trials by
the Empire Rheumatism Council in 1960 (8) have
confirmed the beneficial effect of gold drugs, and
according to recent medical opinion (9) they are as
effective as any other available drug for the difficult
cases and are among the few that can alter the course
of the disease. Although some patients can safely
remain on gold therapy for many years, about 35 per
cent do suffer some toxic side-reactions.
The search for less toxic gold drugs has recently
lead to animal trials of Au(I)-phosphines.
Au(1)-phosphines
Gold-phosphine complexes of the type R 3P AuX
(X—halide, R=alkyl) have been known since about
1870 and are readily prepared from Au(III) and two
equivalents of phosphine. They possess remarkable
stability and can usually be distilled without decom-
position at low pressures. However, it is only recently
that they have been tested for anti-inflammatory
activity. Workers at Smith, Kline and French
Laboratories in Philadelphia not only find that they
are effective against polyarthritis in experimental
animals, but also that they can be administered orally
(10, 11, 12), whereas aurothiomalate is effective only
when given intramuscularly. Moreover harmful
retention of gold by the kidney is very much reduced.
Table III lists some active Au(I)-phosphine drugs and
also some inactive ones. They have recently prepared
and tested a wide variety of these derivatives.
The best therapeutic response is accompanied by
the highest serum gold level, and the extent of absorp-
tion is dependent on the nature of the phosphine. The
ethyl phosphine derivatives appear to be the most
active.
Gold Drugs in Solution
Unlike many organic drugs the active form of a
metallodrug in vivo may not be that indicated by the
molecular formula. For example, the new anti-
tumour drug cis-Pt(NH 3)2C1 2 is thought to hydrolyse
CH	 Glycerol peaks	 CH
Fig. 3 '11 NMR spectra of
auriothiomalate (0.3 M).
Commercially available
samples contain about 0.3
moles of glycerol per auro-
thiomalate (the areas under
the peaks are proportional to
amounts present). Dramatic
changes in the CH and CH,
peaks of aurothiomalate occur
on adding NaCl(1M). This
change is not seen with
thiomalate itself, and is due to
association of aurothiomalate
molecules 3	 2	 ppm from Bu OH(ref)
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upon entering cells to give the reactive species
cis-Pt(NH 3) 2(H 2O)Cl+, and the diaquo form. It has
recently been pointed out (13) that aurothiomalate
will have at least 2-coordinate Au(I) in solution.
Ultracentrifuge and other measurements have demon-
strated (14) the ease of polymerisation of this drug in
solution and that the process is dependent on the
other ions in solution and can occur in blood serum.
The changes in the xH nuclear magnetic resonance
spectrum of aurothiomalate on addition of salt,
Table Ill
Potential Au(I)-Phosphine Anti-inflammatory Gold Drugs in Clinical Use
Effective Orally*	 Ineffective Orally**
R,P —Au—Cl / S—Au—S\
R=Me, Et, i-Pr, n-Bu	 EtOC	 / OEt
(best is R=Et)	 S—Au—S
R,P—Au—S—CH-CH 5CO 2H	 S—Au---S^
CO ZH	 (n-Pr),. N- \	 C—N(n-Pr)2
R = alkyl, alkoxyl, phenyl.	 S—Au—S
R IR 2P— (CH 2)n-----S	 (C6H5)2 P----CH2—`--CH2—P(C8H5),
Au	 Au	 Au	 Au
+S—(CH 5)n—P R 1R 2 	S-CH2CH2S-
(best is n = 2; R„ R 2 =C 1 to C, alkyl)
*Effective against hindleg inflammation produced by a bacterium injected into the hindpaw of a rat
**Probably due to Iack of absorption into bloodstream
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Fig. 4 Section of human synovium from a patient with rheumatoid arthritis currently
receiving aurothiomalate. The greatly inflamed.subintina (area A) contains many cells
laden with gold grains (black deposits), separated from the deeper joint tissue (area C)
by a layer of fatty tissue (area B). (B. Vernon-Roberts and J. L. Dore) ><300
Table IV
Gold Derivatives of Crystalline Proteins and Enzymes
Gold Labelling Protein or Molecular Gold Binding Reference
Agent Enzyme Weight Sites*
AuI(CN)2 flavodoxin 15,000 Cys 128 16
(Cys 53)
carbonic 30,000 His 128/H2O 17
anhydrase (see Figure 5**)
liver alcohol 80,000 Cys 240 (adenine 18
dehydrogenase hydrophobic pocket)
AuI"IC14- cytochrome C e 12,000 His 42 (Asp 3) 19
lysozyme 14,600 Arg 14 20
myoglobin 17,800 His B5/His GH1 21
adenylate kinase 22,000 Cys? 22
yeast phosphoglycerate 45,000 Cys ? 23
kinase
haemoglobin (bloodworm) 68,000 Cys 30 (His 72) 24
lactate dehydrogenase 140,000 Cys 25
AuI, Bence-Jones protein 12,500 ? 26
(part of an inununo-
globulin)
myoglobin 17,000 close to the haem group 21
chymotrypsin 25,300 ? 27
*In some cases the exact nature of the binding groups for gold is uncertain, and the resolution of the X-ray structure determination is
often insufficient to define completely the gold coordination sphere. The numbers refer to the position of the amino acid in the protein;
for further details see references.
**Dr. S. Lindsltog has informed me that the residue labelled HIS 126 in Figure 5 is now thought to bee phenylalanine residue, Phe 129, which





Fig. 5 The binding site for linear Au(CN)x ion on the enzyme carbonic anhydrase, as seen by X-ray crystallo-
graphy. On the left in (A) is shown schematically the outline of the polypeptide backbone of the enzyme. The
black sphere is Zn2+ bonded to 3 histidine side chains. Au(CN)y binds in the vicinity of Zn 2+ as shown
in the close-up in (B) (from 17)
shown in Figure 3, clearly indicate a structural
change, and the behaviour of the thiomalate ligand
can also be observed by F 3C NMR spectroscopy.
Once aurothiomalate enters the serum it is largely
taken up by a protein called albumin, and details of
its ultimate target sites are beginning to emerge.
Site of Action
After injection aurothiomalate seems to enter many
cells in the body, but a closer examination shows that
much gold occurs in localised deposits. Figure 4
shows a section of human synovium from a patient on
gold therapy. The gold is found in localised deposits
within cells, called macrophages, which are usually
responsible for the removal of "foreign bodies".
These cells may contain enzymes responsible for
rheumatoid inflammation, and gold may be inhibiting
their action.
The sites of gold deposition in tissues is elegantly
demonstrated by the use of photochemical techniques
(15). After staining the tissue section with silver
ions, exposure to light followed by a developing
procedure leaves deposits of metallic silver at gold
sites and these are readily seen in the electron
microscope. Sensitisation of silver halide emulsions
by gold salts is well-known and this procedure, as
well as further stains for other parts of the cell, was
used to obtain Figure 1, on page 111, which shows a
kidney section. Hold-up of gold here can cause
toxicity problems.
A full understanding of the action of gold drugs
requires a knowledge of gold binding at the molecular
level. For example, how gold ions interact with
enzymes and proteins.
Enzymes and Proteins
For several years crystallographers have been
labelling crystalline enzymes and proteins with gold
as an essential step for solving a. phasing problem
when determining three-dimensional structures by
X-ray methods. Gold has a high X-ray scattering
power, and can readily be located in the electron
density map. In Table IV some example's are listed,
while Figure 5 shows that the gold-binding site on a
biological macromolecule can be pin-pointed. Either
the gold labelling-agent is co-crystallised with the
enzyme or—more usually—diffused into enzyme
crystals. Although in some cases the exact details of
the gold coordination sphere are unclear in the final
three-dimensional structure, we shall see further
refinements here. It is clear that the species used for
labelling is not necessarily that which binds. For
example, although KAuI 4 may be used, decomposition
in solution is well-known:
AuI4 -_ AuI2 + 1 2
and the enzyme may therefore become labelled with
Au(I).
From Table IV it can be seen that gold often binds
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Fig. 6 A protein is a polymer of amino
acids. Part of a protein containing the
amino acids histidine and cystcine is
shown. These are targets for Au(IU)
and Au(I) binding as shown in Table
IV
by the amino acid cysteine, shown in Figure 6, and
there are many important enzymes now known to
require a free Cys SH group for activity. If this is
blocked with gold the enzyme cannot function. The
next step is to crystallise enzymes in the presence of
gold thiol and phosphine anti-inflammatory drugs.
Fig. 7 Colloidal gold markers on the surface of Cam/ida
«(ihr (fungus) cells. When these cells are introduced into the
bloodstream of an animal, antibodies (large proteins) are
produced which bind to the surface of these foreign cells to
bring about their destruction. By adsorbing the antibodies
on to 60 nm colloidal gold particles, and then allowing them
to bind to the cells, the distribution of antibody sites on the
cell surface is readily revealed in the scanning electron
microscope, as shown (28)
Labelling biological material for viewing by electron
microscopy can also be very fruitful. The most
popular label is colloidal gold.
Colloidal Gold
The reduction of Au(III) compounds in aqueous
solution frequently leads to gold particles dispersed in
a homogeneous medium, i.e., a colloidal solution.
These are usually attractively coloured, ranging from
red (small particles), violet, to blue (large particles),
and are very stable. The Royal Institution in London,
for example, still has three blue/ruby-coloured
colloidal gold solutions prepared by Faraday in 1856.
Flocculation occurs easily in the presence of salts,
and to maintain a colloid with small particle size a
protein, such as albumin, can be added. This
interaction between colloidal gold and the protein
can be used to advantage.
For example, if an antibody binds to the surface
of the cell it cannot be seen under the electron
microscope, since the electron scattering power of all
Fig. 8 A double labelling experiment with colloidal gold on
Candid! Wilk cells. The first marker is Concanavalin A
(a protein which binds specifically to the carbohydrate
mannan) adsorbed on to 40 mit colloidal gold particles. This
identifies the mannan sites on the surface ( f ). The second
markers are antibodies adsorbed on to 80 mit colloidal gold
particles which locate non•mannan sites (T t ). The first
marker is distributed homogeneously, but the second occurs
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Fig. 9 (A) The nucleotide adenosine monophosphate, a constituent of RNA.
(B) Possible structure of an Au(III).adenosine adduct (32)
the atoms, mainly C,H 2O,N, is very low. However,
an antibody labelled with colloidal gold can often
retain its ability to bind to a cell surface, and the
dense region of gold, with its high electron scattering
power, is now a well-contrasted marker. Figures 7
and 8 illustrate how mannan receptors at the surface
of the fungus cells candida utilis can be localised by
stabilised colloidal gold granules coated with either
anti-mannan antibodies or the mannan-binding
protein concanavalin A (28).
The double labelling technique is possible because
the particles can be prepared with defined sizes.
The method of Frens (29) involves reduction of
HAuC14 with sodium citrate and gives monodisperse
solutions with particles of average diameter 160 up
to 1470 A. Flocculation of protein-coated granules
in the presence of excess protein can be prevented
by addition of polyethylene glycol (28).
The uptake of radioactive colloidal gold has been
recommended (30) as a convenient assay for cellular
hypersensitivity, since there is an enhanced uptake
of colloidal gold by macrophages isolated from guinea
pigs sensitised by tuberculin. A specific chemical
substance appears to be released by lymphocytes
(cells which produce antibodies) to stimulate the
uptake of colloidal gold by macrophages. To label
the genetic material of cells, rather than proteins,
Au(III) has been advocated.
Au(III) -Nucleic Acids
The storage and transmission of genetic information
in cells is provided by the macromolecular nucleic
acids deoxyribonucleic acid (DNA) and ribonucleic
acid (RNA). The individual nucleotide units are
joined by phosphate-ester linkages. A brown gold
DNA adduct can be isolated from chloroaurate-DNA
mixtures (31). Au(III) has a high affinity for N
ligands and, in particular, for NH2 groups. Strong
complexes are formed with adenine nucleotides, for
example, as shown in Figure 9 (32). The gold-
adenine nucleotide adducts have potential applica-
tions in cytochemistry to identify intracellular enzyme
sites. The enzyme acid phosphatase cleaves the
phosphate group and an electron dense product is
deposited at the enzyme site and is seen in the elec-
tron micrograph (33).
Polyadenylic acid can be stained with HAuC1 4 to
produce a three-fold enhancement in contrast when
viewed by electron microscopy. The staining can be
selective for nucleotides. Polyuridylic acid (no NH 2
groups) is not stained.
Binding of Au(III) to DNA could interfere with
cell division process, but this is just what might be
required of a potential Au(III) anti-tumour agent.
It is with great interest that we await further news of
the compound [Au(5-du) 2C1 2]Cl.HC1 which has
recently been reported to show anti-tumour activity
in mice (34). 5-du is 5-diazouracil.
Gold and Obesity
It is now well-established (35, 36) that injection of
aurothioglucose into mice results in obesity. In-
creases in body-weight by up to one-third have been
observed, and the effect is specific for aurothio-
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glucose; the thiomalate, thiocaproic acid, thioglycerol,
thioglycoanilide and thiosulphate derivatives of Au(I)
are inactive. Evidently a specific in vivo glucose
receptor is destroyed by the presence of gold. Such
studies may improve our understanding of the nature
of obesity.
Conclusion
There is widespread interest in the effect of gold
compounds on biological systems, especially since,
with the aid of modern physical techniques, we can
begin to map out the activity of gold in molecular
terms. We can often locate gold inside cells and in
some cases pin-point its binding sites on macro-
molecules such as enzymes. As this knowledge in-
creases, so the design of new gold compounds, either
as metallodrugs or as heavy-atom labels, will un-
doubtedly improve.
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Gold Coated Glass for Solar Insulation
Several methods of reducing the effects of solar
radiation in buildings are now available, including the
use of a gold film applied to the inner surface of the
outside panes of windows. This gold coating allows
part of the visible radiation to pass through while
reflecting much of the infra-red. In a paper by
Werner Klein of the Jenaer Glaswerk Schott und
Genossen in Mainz, West Germany (Glass, 1976,
53, (3), 91-94), the special property of gold that makes
it suitable for this purpose is described-its low
emission coefficient for long-wave radiation. Thus
gold coating emits less long-wave radiation to the
inside of a room than the outside pane emits to the
atmosphere. In addition, this property of gold results
in a considerable improvement in thermal insulation in
winter by a marked improvement in the coefficient of
heat transfer.
The intensive reflection colour from gold-coated
glass does, however, pose one problem to the architect.
This has been largely overcome by the introduction of
reflection-reducing interference layers to give blue-to-
violet reflection colours that are architecturally attrac-
tive, while they increase substantially the amount of
light transmitted in the yellow-to-green region.
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